<i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Giuseppe Sconocchia|International Journal of Cancer|2019Cited by 40
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Giuseppe Sconocchia|Experimental Hematology and Oncology|2025Cited by 2
Elimination of Egfr-Overexpressing Cancer Cells by CD32 Chimeric Receptor T Cells in Combination with Cetuximab or PanitumumabSara Caratelli, Giuseppe Sconocchia|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 0
The CD64/CD28/CD3 ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Giuseppe Sconocchia|Research Square|2024Cited by 0